- THE ROLE OF THE ENDOTHELIUM IN CYSTIC FIBROSIS ASSOCIATED LIVER DISEASE(2021)
Auteurs: Mathias Declercq, Peter Witters, Lucas Treps, Peter Carmeliet
- Comparative meta-analysis of cystic fibrosis cell models suggests partial endothelial-to-mesenchymal transition(2021)
Auteurs: Mathias Declercq, Peter Carmeliet, Peter Witters
Pagina's: 876 - 880
- Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension(2021)
Auteurs: Mathias Declercq, Peter Carmeliet, Peter Witters
- Transcriptomic analysis of CFTR-impaired endothelial cells reveals a pro-inflammatory phenotype(2021)
Auteurs: Mathias Declercq, Vincent Geldhof, Marjolein Ensinck, Marianne Carlon, Matthew Bird, Marijke Proesmans, François Vermeulen, Lieven Dupont, Bart Ghesquière, Mieke Dewerchin, et al.
- Two cases of non-alcoholic fatty liver disease caused by biallelic ABHD5 mutations(2020)
Auteurs: Isabelle Adant, Mathias Declercq, Matthew Bird, Nancy Boeckx, Koenraad Devriendt, David Cassiman, Peter Witters
Pagina's: 1030 - 1032
- The role of endothelial cells in cystic fibrosis(2019)
Auteurs: Mathias Declercq, Lucas Treps, Peter Carmeliet, Peter Witters
Pagina's: 752 - 761
- BRAF, A gatekeeper controlling endothelial permeability(2019)
Auteurs: Mathias Declercq, Lucas Treps
Pagina's: 2273 - 2276
- P021 CFTR loss of function leads to increased ROS and endothelial dysfunction(2019)
Auteurs: Mathias Declercq, Lucas Treps, Bart Ghesquière, Peter Carmeliet, Peter Witters
Pagina's: S62 - S63
- BRAF, A gatekeeper controlling endothelial permeability(2019)
Auteurs: Mathias Declercq, Lucas Treps
Pagina's: 2273 - 2276